Maison David P, Tasissa Hawi, Deitchman Amelia, Peluso Michael J, Deng Youping, Miller F DeWolfe, Henrich Timothy J, Gerschenson Mariana
Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI, United States.
Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Front Public Health. 2025 Jan 31;13:1498445. doi: 10.3389/fpubh.2025.1498445. eCollection 2025.
Coronavirus Disease 2019, caused by severe acute respiratory coronavirus 2, has been an ever-evolving disease and pandemic, profoundly impacting clinical care, drug treatments, and understanding. In response to this global health crisis, there has been an unprecedented increase in research exploring new and repurposed drugs and advancing available clinical interventions and treatments. Given the widespread interest in this topic, this review aims to provide a current summary-for interested professionals not specializing in COVID-19-of the clinical characteristics, recommended treatments, vaccines, prevention strategies, and epidemiology of COVID-19. The review also offers a historical perspective on the pandemic to enhance understanding.
2019冠状病毒病由严重急性呼吸综合征冠状病毒2引起,是一种不断演变的疾病和大流行,对临床护理、药物治疗及认知产生了深远影响。为应对这一全球健康危机,探索新型和重新利用药物以及推进现有临床干预措施和治疗方法的研究出现了前所未有的增长。鉴于对该主题的广泛关注,本综述旨在为非COVID-19专业的相关专业人士提供关于COVID-19的临床特征、推荐治疗方法、疫苗、预防策略及流行病学的当前总结。本综述还提供了关于此次大流行的历史视角,以增进理解。